EUVIMEDSkopri EUVIMED
StudienprotokollOpen access

Normalization of Gastrointestinal Symptoms in Adults With Constipation With Daily Green Kiwifruit Consumption: Protocol for an Open-Label Intervention Study

Jasjot Maggo iD, Hwei Min Ng iD, Simone Birgit Bayer iD, Catherine L Wall iD, Caroline L Hoad iD, Luca Marciani iD, Jane Mullaney iD, Diana Cabrera iD, Karl Fraser iD, Janine M Cooney iD, Catrin S Günther iD, Tania Trower iD and 10 more

JMIR Research Protocols · 2026

DOI: 10.2196/75286 ↗

At a glance

Studienprotokoll in JMIR Research Protocols, 2026. Written by Jasjot Maggo and 21 co-authors. Institution: Department of Medicine, Christchurch, University of Otago, 2 Riccarton Avenue, Christchurch, 8011, New Zealand, 64 3 244 1074. Major MEDLINE topics: Actinidia, Constipation, Irritable Bowel Syndrome, Fruit. 94 references. The full text is freely available in PubMed Central.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Background

Irritable bowel syndrome with constipation (IBS-C) and functional constipation (FC) have significant personal, health care, and social impacts, affecting patients’ quality of life. Treatment of these conditions is challenging. While green kiwifruit is a promising natural alternative to laxatives, its effectiveness in managing abdominal pain and the underlying mechanism of action is yet to be substantiated.

Objective

This study investigates the effect of consuming 2 green kiwifruit daily for 4 weeks (the habitual serving) on abdominal pain and discomfort in individuals with IBS-C and FC.

Methods

This study is a 2-arm parallel, open-label, placebo-controlled randomized study. This study’s duration was 9 weeks, with a 3-week lead-in phase, a 4-week intervention phase, and a 2-week follow-up phase. A total of 60 participants with IBS-C and FC were randomized to consume either 2 Zespri green kiwifruit ( Actinidia deliciosa “Hayward,” ~150 g per serving, ~90 kcal) or maltodextrin (calorie-matched to the fruit, ~25 g per serving, ~90 kcal) per day for 4 weeks. The participants completed validated questionnaires assessing digestive and general health and well-being parameters, underwent magnetic resonance imaging to determine colon physiological measures, ingested a blue food dye, provided blood and fecal samples to measure microbial, immunological, and biochemical parameters, and ingested wireless motility devices (selected participants only) to assess physiological processes.

Results

Recruitment for this study began in May 2021 and was completed in May 2022. A total of 63 participants were randomized, and 57 were analyzed using intention-to-treat analysis. Data analysis is complete, and full results are expected to be published in a peer-reviewed journal by April 2026.

Conclusions

This study aims to evaluate the effectiveness of green kiwifruit consumption in managing abdominal pain in individuals with IBS-C and FC. It will provide new insights into the mechanisms behind the habitual consumption of green kiwifruit for digestive comfort in this population.

Subjects

MeSH terms (MEDLINE)

ActinidiaConstipationIrritable Bowel SyndromeFruitHumansAdultFemaleMaleMiddle AgedAbdominal PainQuality of LifeRandomized Controlled Trials as Topic

Author keywords

abdominal paincolonic volumeconstipation-predominant irritable bowel syndromefunctional constipationgreen kiwifruitgut microbiomemetabolitesmobile phonerandomized control trial

Authors and institutions

  • Department of Medicine, Christchurch, University of Otago, 2 Riccarton Avenue, Christchurch, 8011, New Zealand, 64 3 244 1074.
  • High Value Nutrition National Science Challenge, Auckland, New Zealand.
  • NIHR (National Institute for Health and Care Research) Nottingham Digestive Diseases Biomedical Research Unit, Nottingham University Hospitals NHS (National Health Service) Trust and the University of Nottingham, Nottin…
  • Grasslands, AgResearch, Palmerston North, New Zealand.
  • Riddet Institute, Massey University, Palmerston North, New Zealand.
  • Plant and Food Research, Palmerston North, New Zealand.

ORCID profiles: Jasjot Maggo, Hwei Min Ng, Simone Birgit Bayer, Catherine L Wall, Caroline L Hoad, Luca Marciani, Jane Mullaney, Diana Cabrera, Karl Fraser, Janine M Cooney, Catrin S Günther, Tania Trower, Jeffery Tang, Olivier Gasser, Amber Milan, Warren C McNabb, Robin Spiller, Tamlin Conner, Chris Frampton, Meika Foster, Nicole C Roy, Richard B Gearry

Cite

APA

Maggo, J., Ng, H. M., Bayer, S. B., Wall, C. L., Hoad, C. L., Marciani, L., Mullaney, J., Cabrera, D., Fraser, K., Cooney, J. M., Günther, C. S., Trower, T., Tang, J., Gasser, O., Milan, A., McNabb, W. C., Spiller, R., Conner, T., Frampton, C., …, & Gearry, R. B. (2026). Normalization of Gastrointestinal Symptoms in Adults With Constipation With Daily Green Kiwifruit Consumption: Protocol for an Open-Label Intervention Study. JMIR Research Protocols. https://doi.org/10.2196/75286

Vancouver

Maggo J, Ng HM, Bayer SB, Wall CL, Hoad CL, Marciani L, et al. Normalization of Gastrointestinal Symptoms in Adults With Constipation With Daily Green Kiwifruit Consumption: Protocol for an Open-Label Intervention Study. JMIR Research Protocols. 2026. doi:10.2196/75286

BibTeX
@article{Maggo2026,
  author = {Maggo, Jasjot and Ng, Hwei Min and Bayer, Simone Birgit and Wall, Catherine L and Hoad, Caroline L and Marciani, Luca and Mullaney, Jane and Cabrera, Diana and Fraser, Karl and Cooney, Janine M and Günther, Catrin S and Trower, Tania and Tang, Jeffery and Gasser, Olivier and Milan, Amber and McNabb, Warren C and Spiller, Robin and Conner, Tamlin and Frampton, Chris and Foster, Meika and Roy, Nicole C and Gearry, Richard B},
  title = {Normalization of Gastrointestinal Symptoms in Adults With Constipation With Daily Green Kiwifruit Consumption: Protocol for an Open-Label Intervention Study},
  journal = {JMIR Research Protocols},
  year = {2026},
  doi = {10.2196/75286}
}
Start for free →